Pfizer unit wins $107.5M verdict in cancer-drug patent case against AstraZeneca
A Delaware federal jury has ordered AstraZeneca to fork over $107.5 million to Pfizer for infringing two of the latter company's patents with its marketing of blockbuster oncology med Tagrisso. In the case, Pfizer subsidiary Wyeth and Puma …